Anuario CAPCorp 2026

Principales inversiones de Capital Riesgo

% ADQUIRIDO (% ALCANZADO)

DEAL VALUE €M (DEUDA ASUMIDA)

EMPRESA

INVERSOR

TIPO

ASESORES

Startup Wise Guys Easo Ventures Briseida Ventures Broom Logistic Nueso Group Koala Smart Business Recalvi Parts (controlada por Abac Capital)

Cloudtainer

p. minoritaria

0,218

Seed Capital

L: Lawesome

Iberoturbo Grupo Bomboleo

100%

VF: Solventis DDF/L/Fiscal/Laboral: KPMG

Conf.

Build up

Wecaria

DevelSeed

p. minoritaria

Conf.

Seed Capital

VF: Solventis VL: Maio Legal CL: EY DDF/L/Fiscal/Laboral/ESG: KPMG

Abac Capital (Abac SV Fund II y Abac S Value II)

Recalvi Parts

p. mayoritaria

Conf.

LBO

BIOTECNOLOGÍA

VF: PwC CF/Financiación: Alantra CL: Latham & Watkins VDDF/L/Fiscal: PwC DDF/Fiscal: KPMG DDComercial: Roland Berger

Ambienta José Manuel Casanova Management

Agronova Biotech

100%

Más de 200 SBO

EQT Life Sciences Sanofi Ventures Roche Venture Fund New Enterprise Associates UCB Ventures Ysios Capital Gilde Healthcare Novartis Venture Fund Asabys Partners Ysios Capital Fidelity Viking Global Investors Cormorant Asset Management The Column Group Lyfe Capital Schroders Capital Willett Advisors Euclidean Capital SymBiosis Alexandria Venture Investments Berkeley Frontier Fund Sphera Biotech Master Fund Spur Capital Partners UCB Ventures UC Investments Asabys Partners Novo Holdings Jeito Capital Eli Lilly and Company Gemma Frisius Fund Charcot-Marie-Tooth (CMT) Research Foundation Bpifrance (Large Venture e InnoBio) AdBio Partners CDTI Innovación Columbus Venture Partners European Innovation Council (EIC) Hadean Ventures Invivo Partners Sound Bioventures AdBio Partners V-Bio Ventures PMV VIB

Venture Capital

SpliceBio

p. minoritaria

119

CL: Cuatrecasas

Venture Capital

Neurona Therapeutics

p. minoritaria

92

Venture Capital

Augustine Therapeutics

p. minoritaria

77,7

Venture Capital

Arthex Biotech

p. minoritaria

75

59

Powered by